June Fabian1,2, Jaya A George3,4, Sean D Currin5,6, Mwawi S Gondwe1, Nokthula B Mayindi1, Shingirai Chipungu1, Bongekile L Khoza1, Stephen Tollman1,7. 1. Faculty of Health Sciences, Medical Research Council/Wits University Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, University of Witwatersrand, Johannesburg, South Africa. 2. Wits Donald Gordon Medical Centre, Faculty of Health Sciences, School of Clinical Medicine, University of Witwatersrand, Johannesburg, South Africa. 3. Department of Chemical Pathology, Faculty of Health Sciences, University of Witwatersrand, 7 York Road, Parktown, Johannesburg, 2193, South Africa. 4. National Health Laboratory Service, Johannesburg, South Africa. 5. Department of Chemical Pathology, Faculty of Health Sciences, University of Witwatersrand, 7 York Road, Parktown, Johannesburg, 2193, South Africa. sean.currin@wits.ac.za. 6. National Health Laboratory Service, Johannesburg, South Africa. sean.currin@wits.ac.za. 7. International Network for the Demographic Evaluation of Populations and their Health (INDEPTH) Network, Accra, Ghana.
Abstract
BACKGROUND: The prevalence of chronic kidney disease (CKD) is predicted to rise over the next few decades. In resource-limited settings access to central laboratory services is limited. Point-of-care (POC) urine dipstick testing offers the potential to detect markers of kidney damage (albuminuria) as well as markers of other disease processes. We evaluated the diagnostic accuracy of the semi-quantitative albumin-creatinine ratio (ACR) Sysmex UC-1000 POC urine dipstick system as well as the extent of other abnormal dipstick findings in urine. METHODS: 700 participants from a rural area in South Africa were screened for albuminuria. A spot urine sample was used to measure POC and central laboratory ACR. We determined the sensitivity, specificity, positive predictive value and negative predictive value of the POC ACR, and recorded dipstick parameters. RESULTS: The prevalence of albuminuria was 11.6% (95%CI; 9.3-14.2). Those with albuminuria had higher mean diastolic (82 vs 79 mmHg, p = 0.019) and systolic (133 vs 128 mmHg, p = 0.002) blood pressures and a higher proportion of diabetes mellitus (17.6 vs 4.9%, p < 0.001). The sensitivity of the POC ACR system was 0.79, specificity 0.84, positive predictive value 0.39 and negative predictive value 0.97. The sensitivity improved to 0.80, 0.85, 0.85 and 0.89 in those with elevated blood pressure, diabetes mellitus, HIV positive status, and those 65 years and older, respectively. Abnormalities other than albuminuria were detected in 240 (34.3%) of the samples; 88 (12.6%) were positive for haematuria, 113 (16.1%) for leucocytes, 66 (9.4%) for nitrites and 27 (3.9%) for glycosuria. CONCLUSION: Our study shows that POC ACR has good negative predictive value and could be used to rule out albuminuria when screening for CKD. Additionally, a high proportion of participants had other urine abnormalities detected with dipsticks which may reflect kidney disease or co-morbid untreated genitourinary pathology such as urinary tract infections or endemic schistosomiasis with important implications for CKD.
BACKGROUND: The prevalence of chronic kidney disease (CKD) is predicted to rise over the next few decades. In resource-limited settings access to central laboratory services is limited. Point-of-care (POC) urine dipstick testing offers the potential to detect markers of kidney damage (albuminuria) as well as markers of other disease processes. We evaluated the diagnostic accuracy of the semi-quantitative albumin-creatinine ratio (ACR) Sysmex UC-1000 POC urine dipstick system as well as the extent of other abnormal dipstick findings in urine. METHODS: 700 participants from a rural area in South Africa were screened for albuminuria. A spot urine sample was used to measure POC and central laboratory ACR. We determined the sensitivity, specificity, positive predictive value and negative predictive value of the POC ACR, and recorded dipstick parameters. RESULTS: The prevalence of albuminuria was 11.6% (95%CI; 9.3-14.2). Those with albuminuria had higher mean diastolic (82 vs 79 mmHg, p = 0.019) and systolic (133 vs 128 mmHg, p = 0.002) blood pressures and a higher proportion of diabetes mellitus (17.6 vs 4.9%, p < 0.001). The sensitivity of the POC ACR system was 0.79, specificity 0.84, positive predictive value 0.39 and negative predictive value 0.97. The sensitivity improved to 0.80, 0.85, 0.85 and 0.89 in those with elevated blood pressure, diabetes mellitus, HIV positive status, and those 65 years and older, respectively. Abnormalities other than albuminuria were detected in 240 (34.3%) of the samples; 88 (12.6%) were positive for haematuria, 113 (16.1%) for leucocytes, 66 (9.4%) for nitrites and 27 (3.9%) for glycosuria. CONCLUSION: Our study shows that POC ACR has good negative predictive value and could be used to rule out albuminuria when screening for CKD. Additionally, a high proportion of participants had other urine abnormalities detected with dipsticks which may reflect kidney disease or co-morbid untreated genitourinary pathology such as urinary tract infections or endemic schistosomiasis with important implications for CKD.
Entities:
Keywords:
Chronic kidney disease; Dipstick; Point of care; Urine albumin creatinine ratio
Authors: Malcolm P McTaggart; Christopher P Price; Roger G Pinnock; Paul E Stevens; Ronald G Newall; Edmund J Lamb Journal: Am J Kidney Dis Date: 2012-06-20 Impact factor: 8.860
Authors: Barry I Freedman; Amy L Kistler; Peter Skewes-Cox; Don Ganem; Mitzie Spainhour; Jolyn Turner; Jasmin Divers; Carl D Langefeld; Mariana Murea; Pamela J Hicks; Ashok K Hemal; James A Snipes; Lihong Zhao; Johanna R Abend; Douglas S Lyles; Lijun Ma; Karl L Skorecki Journal: Nephrol Dial Transplant Date: 2018-11-01 Impact factor: 5.992
Authors: Vivekanand Jha; Mustafa Arici; Allan J Collins; Guillermo Garcia-Garcia; Brenda R Hemmelgarn; Tazeen H Jafar; Roberto Pecoits-Filho; Laura Sola; Charles R Swanepoel; Irma Tchokhonelidze; Angela Yee Moon Wang; Bertram L Kasiske; David C Wheeler; Goce Spasovski Journal: Kidney Int Date: 2016-12 Impact factor: 10.612
Authors: Klaus Klausen; Knut Borch-Johnsen; Bo Feldt-Rasmussen; Gorm Jensen; Peter Clausen; Henrik Scharling; Merete Appleyard; Jan Skov Jensen Journal: Circulation Date: 2004-06-21 Impact factor: 29.690
Authors: Jaya A George; Jean-Tristan Brandenburg; June Fabian; Nigel J Crowther; Godfred Agongo; Marianne Alberts; Stuart Ali; Gershim Asiki; Palwende R Boua; F Xavier Gómez-Olivé; Felistas Mashinya; Lisa Micklesfield; Shukri F Mohamed; Freedom Mukomana; Shane A Norris; Abraham R Oduro; Cassandra Soo; Hermann Sorgho; Alisha Wade; Saraladevi Naicker; Michèle Ramsay Journal: Lancet Glob Health Date: 2019-12 Impact factor: 26.763